Tilray Brands Inc (TLRY)
NASDAQ • Healthcare
July 27, 2026 at 20:00 UTC
About Tilray Brands Inc
Tilray Brands, Inc. (NASDAQ: TLRY) operates across cannabis, beverage alcohol, and wellness businesses within the healthcare sector, with FY2025 revenue of $1.1 billion. The company sells medical and adult-use cannabis products, pharmaceutical and wellness goods it procures for resale, alcoholic beverages, and hemp-derived food and other wellness items.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Tilray Brands Inc's Technical Indicators Summary
TLRY exhibits pronounced weakness across timeframes despite some oversold oscillators signaling relief; RSI and stochastic sit deeply oversold while CCI and MACD remain negative. The stock trades well below its short-, medium- and long-term moving averages, and ADX in the mid-20s confirms a meaningful downtrend. ATR about $0.21 (roughly 5.4%) shows elevated percentage volatility for the share price, and OBV is strongly negative, pointing to heavy selling pressure. The classic pivot around 4.02 is above the current price, reinforcing resistance. Technical takeaway: Strong Sell.
| Indicator | Value |
|---|---|
RSI (14) | 23.83 |
Stochastic %K (14, 3, 3) | 6.12 |
CCI (20) | -235.78 |
WPR (14) | -89.87 |
Momentum (10) | -0.54 |
MFI | 28.14 |
MACD Level (12, 26) | -0.23 |
Bollinger Bands | $3.97 - $4.73 |
ATR (14) | $0.21 (5.44%) |
ADX (14) | 25.80 |
OBV | -70,266,429 |
Classic Pivot Point | $4.02 |
Fibonacci Pivot Point | $4.02 |
Exponential Moving Averages | $4.19 - $7.71(5 indicators) |
Simple Moving Averages | $4.24 - $8.10(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Buying out of the gate leaves TLRY 3.99% above yesterday’s close (3.88). Earnings land in 1 day on 28 July, setting up a pre-release period for TLRY. TLRY outlines dividends and stock-split history, with an event timeline that could spark near-term action.
Trading Volume
Below 10d avg (3.6M)
2.7M
vs S&P 500 Today
Strong Outperformance
+4.16%
52-Week Position
Near lows
1.2%
Updated: July 27, 2026 at 19:14 UTC
Quote Summary
TLRY Headlines
Tilray to Acquire HelloMD’s Canada Assets
June 29, 2026
Front-Side Shorts Crowd Into Avis Spike
April 9, 2026